ANGPTL4: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
== Overview of ANGPTL4 == | |||
[[File:Overview_ANGPTL4.png|thumb|right|Diagram illustrating the structure and function of ANGPTL4]] | |||
[[ | |||
'''ANGPTL4''' (Angiopoietin-like 4) is a protein that plays a significant role in lipid metabolism, energy homeostasis, and inflammation. It is a member of the [[angiopoietin-like protein]] family, which is known for its involvement in various physiological processes, including [[angiogenesis]], lipid metabolism, and glucose homeostasis. | |||
ANGPTL4 is a | |||
== | == Structure == | ||
ANGPTL4 is a glycoprotein that consists of several distinct domains, including a coiled-coil domain and a fibrinogen-like domain. These domains are crucial for its function and interaction with other molecules. The protein is secreted as a full-length molecule and can be cleaved into N-terminal and C-terminal fragments, each having distinct biological activities. | |||
== | == Function == | ||
ANGPTL4 is primarily involved in the regulation of [[lipid metabolism]]. It inhibits the activity of [[lipoprotein lipase]] (LPL), an enzyme critical for the hydrolysis of triglycerides in lipoproteins. By inhibiting LPL, ANGPTL4 increases plasma triglyceride levels and influences the distribution of lipids in the body. | |||
== | In addition to its role in lipid metabolism, ANGPTL4 is also involved in [[energy homeostasis]] and [[inflammation]]. It is expressed in various tissues, including the [[liver]], [[adipose tissue]], and [[muscle]], and its expression is regulated by nutritional and hormonal signals. | ||
== Clinical Significance == | |||
ANGPTL4 has been implicated in several metabolic disorders, including [[hyperlipidemia]], [[obesity]], and [[type 2 diabetes]]. Its role in inhibiting lipoprotein lipase makes it a potential target for therapeutic interventions aimed at lowering plasma triglyceride levels and improving lipid profiles in patients with metabolic syndrome. | |||
Furthermore, ANGPTL4 has been studied for its role in [[cancer]] and [[cardiovascular disease]]. Its ability to modulate angiogenesis and inflammation suggests that it may have broader implications in disease pathogenesis beyond metabolic disorders. | |||
== Related Pages == | |||
* [[Lipoprotein lipase]] | * [[Lipoprotein lipase]] | ||
* [[Lipid metabolism]] | |||
* [[Angiogenesis]] | * [[Angiogenesis]] | ||
* [[Metabolic syndrome]] | * [[Metabolic syndrome]] | ||
[[Category:Proteins]] | [[Category:Proteins]] | ||
[[Category:Metabolism]] | [[Category:Metabolism]] | ||
[[Category:Human proteins]] | |||
Latest revision as of 03:34, 13 February 2025
Overview of ANGPTL4[edit]

ANGPTL4 (Angiopoietin-like 4) is a protein that plays a significant role in lipid metabolism, energy homeostasis, and inflammation. It is a member of the angiopoietin-like protein family, which is known for its involvement in various physiological processes, including angiogenesis, lipid metabolism, and glucose homeostasis.
Structure[edit]
ANGPTL4 is a glycoprotein that consists of several distinct domains, including a coiled-coil domain and a fibrinogen-like domain. These domains are crucial for its function and interaction with other molecules. The protein is secreted as a full-length molecule and can be cleaved into N-terminal and C-terminal fragments, each having distinct biological activities.
Function[edit]
ANGPTL4 is primarily involved in the regulation of lipid metabolism. It inhibits the activity of lipoprotein lipase (LPL), an enzyme critical for the hydrolysis of triglycerides in lipoproteins. By inhibiting LPL, ANGPTL4 increases plasma triglyceride levels and influences the distribution of lipids in the body.
In addition to its role in lipid metabolism, ANGPTL4 is also involved in energy homeostasis and inflammation. It is expressed in various tissues, including the liver, adipose tissue, and muscle, and its expression is regulated by nutritional and hormonal signals.
Clinical Significance[edit]
ANGPTL4 has been implicated in several metabolic disorders, including hyperlipidemia, obesity, and type 2 diabetes. Its role in inhibiting lipoprotein lipase makes it a potential target for therapeutic interventions aimed at lowering plasma triglyceride levels and improving lipid profiles in patients with metabolic syndrome.
Furthermore, ANGPTL4 has been studied for its role in cancer and cardiovascular disease. Its ability to modulate angiogenesis and inflammation suggests that it may have broader implications in disease pathogenesis beyond metabolic disorders.